Terms & Conditions

Schering Corporation invites residents of the United States to access and use this Internet site subject to the terms and conditions below and all applicable laws. This site and all information contained therein is intended for access and use by such residents only.

You may download and retain on your disk or in hard copy form a single copy of material published on this site for your personal use, provided that you do not remove any proprietary notices. You may not otherwise copy, distribute, display, download, modify, or repost all or part of any material without Schering Corporation's written permission. You may not mirror on another Web server all or part of any material published by Schering Corporation on this site, and you may not inline any of the graphics contained in any material published on this site.

Schering Corporation will use reasonable efforts to include accurate and up-to-date information on this site, but makes no representations or warranties as to its accuracy or completeness. Access to and use of the content is at your own risk, and neither Schering Corporation nor any party involved in creating or delivering this site shall be liable to you for any damage of any kind arising out of your access, use or inability to access or use this site, or for any omissions or errors in its content.

Schering Corporation reserves the right to alter or delete material from this site at any time.

Schering Corporation may revise these terms and conditions periodically.

PROVENTIL® HFA Inhalation Aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Albuterol (CFC) Inhalation Aerosol is indicated in patients 12 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Important Safety Information
If your symptoms become significantly worse when you use PROVENTIL® HFA or Albuterol (CFC) Inhalation Aerosols, contact your doctor immediately because this reaction can be life threatening. Worsening symptoms often occur with the first use of a new canister.

What to tell your doctor before using PROVENTIL® HFA or Albuterol (CFC) Inhalation Aerosols: If you have a heart, blood, or seizure disorder, high blood pressure, diabetes, or an overactive thyroid, be sure to tell your doctor. Also make sure your doctor knows all medications you are taking — especially heart medications and drugs that treat depression — because some medications may interfere with how well your asthma medications work.

Side effects with PROVENTIL® HFA and Albuterol (CFC) Inhalation Aerosols are similar: In a clinical study, side effects associated with PROVENTIL® HFA and Albuterol (CFC) Inhalation Aerosols were similar and included infection of the ears, nose, and throat, runny nose, nausea, tremor, and nervousness. Rapid heart beat, vomiting, chest pain, and palpitation occurred more frequently with PROVENTIL® HFA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For additional important product information, see The PROVENTIL® HFA Package Insert.
For additional important product information on the Warrick inhaler, see The Albuterol Package Insert.

Note: The information on this site is not intended to be a substitute for professional medical advice. If you have any questions about your treatment or medical condition, please consult your doctor or other qualified health care provider.

Available by prescription only.

This site is intended for use by U.S. residents.